ATE203754T1 - Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung - Google Patents

Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung

Info

Publication number: ATE203754T1
Authority: AT; Austria
Prior art keywords: peptides; peptide derivatives; somatostatin; image; radioactive
Prior art date: 1992-06-23

Application number

AT93918129T

Other languages

English (en)

Inventor

Richard T Dean

John Lister-James

Original Assignee

Diatide Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-23

Filing date

1993-06-23

Publication date

2001-08-15

1993-06-23 Application filed by Diatide Inc filed Critical Diatide Inc

2001-08-15 Application granted granted Critical

2001-08-15 Publication of ATE203754T1 publication Critical patent/ATE203754T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 5
238000000034 method Methods 0.000 abstract 3
239000003153 chemical reaction reagent Substances 0.000 abstract 2
238000000163 radioactive labelling Methods 0.000 abstract 2
WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 abstract 1
102000005157 Somatostatin Human genes 0.000 abstract 1
108010056088 Somatostatin Proteins 0.000 abstract 1
GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
WUAPFZMCVAUBPE-IGMARMGPSA-N rhenium-186 Chemical compound [186Re] WUAPFZMCVAUBPE-IGMARMGPSA-N 0.000 abstract 1
229960000553 somatostatin Drugs 0.000 abstract 1
229940056501 technetium 99m Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Optics & Photonics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Zoology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT93918129T 1992-06-23 1993-06-23 Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung ATE203754T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/902,935 US5716596A (en)	1992-06-23	1992-06-23	Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
PCT/US1993/006029 WO1994000489A2 (en)	1992-06-23	1993-06-23	Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses

Publications (1)

Publication Number	Publication Date
ATE203754T1 true ATE203754T1 (de)	2001-08-15

Family

ID=25416650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93918129T ATE203754T1 (de)	1992-06-23	1993-06-23	Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung

Country Status (10)

Country	Link
US (5)	US5716596A (de)
EP (2)	EP1094074A3 (de)
JP (1)	JPH08503924A (de)
AT (1)	ATE203754T1 (de)
AU (1)	AU690071B2 (de)
CA (1)	CA2138647C (de)
DE (1)	DE69330521T2 (de)
DK (1)	DK0649434T3 (de)
ES (1)	ES2164667T3 (de)
WO (1)	WO1994000489A2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5443816A (en) *	1990-08-08	1995-08-22	Rhomed Incorporated	Peptide-metal ion pharmaceutical preparation and method
US5443815A (en) *	1991-11-27	1995-08-22	Diatech, Inc.	Technetium-99m labeled peptides for imaging
ATE188387T1 (de) *	1991-02-08	2000-01-15	Diatide Inc	Technetium-99m markierte polypeptide zur bildformung
US5736122A (en) *	1991-02-08	1998-04-07	Diatide, Inc.	Technetium-99m labeled peptides for thrombus imaging
US5965107A (en) *	1992-03-13	1999-10-12	Diatide, Inc.	Technetium-99m labeled peptides for imaging
US5849261A (en) *	1991-02-08	1998-12-15	Diatide, Inc.	Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) *	1991-11-27	2007-07-03	Cis Bio International	Monoamine, diamide, thiol-containing metal chelating agents
US5645815A (en)	1991-02-08	1997-07-08	Diatide, Inc.	Radiolabled compounds for thrombus imaging
US5997844A (en) *	1991-02-08	1999-12-07	Diatide, Inc.	Technetium-99m labeled peptides for imaging
US5783170A (en) *	1991-11-27	1998-07-21	Diatide, Inc.	Peptide-metal chelate conjugates
US6183722B1 (en) *	1991-11-27	2001-02-06	Diatide, Inc.	Somatostatin analogs
WO1995000553A1 (en) *	1993-06-23	1995-01-05	Diatech, Inc.	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5968476A (en) *	1992-05-21	1999-10-19	Diatide, Inc.	Technetium-99m labeled peptides for thrombus imaging
US5620675A (en)	1992-06-23	1997-04-15	Diatech, Inc.	Radioactive peptides
US6017512A (en) *	1992-06-23	2000-01-25	Diatide, Inc.	Radiolabeled peptides
US5932189A (en) *	1994-07-29	1999-08-03	Diatech, Inc.	Cyclic peptide somatostatin analogs
JP3320734B2 (ja) *	1993-07-28	2002-09-03	ダイアタイド・インコーポレイテッド	放射性同位体標識したグルカン類
DK96493D0 (da) *	1993-08-26	1993-08-26	Mouritsen Og Elsner Aps	Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0772459B1 (de) *	1994-05-02	2003-03-19	Diatide, Inc.	Technetium-99m markierte bildformungsmittel
US6051206A (en) *	1994-06-03	2000-04-18	Diatide, Inc	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5556939A (en) *	1994-10-13	1996-09-17	Merck Frosst Canada, Inc.	TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5891418A (en) *	1995-06-07	1999-04-06	Rhomed Incorporated	Peptide-metal ion pharmaceutical constructs and applications
US5753206A (en) *	1995-06-07	1998-05-19	Immunomedics, Inc.	Radiometal-binding analogues of luteinizing hormone releasing hormone
MY147327A (en) *	1995-06-29	2012-11-30	Novartis Ag	Somatostatin peptides
DE19536783A1 (de) *	1995-09-21	1997-03-27	Diagnostikforschung Inst	Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope
US6331285B1 (en)	1996-06-05	2001-12-18	Palatin Technologies, Inc.	Structurally determined cyclic metallo-constructs and applications
AU4005697A (en) *	1996-08-23	1998-03-06	Patel, Cell & Receptor Technologies Inc.	Agonist-dependent internalization of human somatostatin receptors types 1-5
DE19980730D2 (de) *	1998-04-28	2001-05-10	Wolfgang Bergter	Radioimmunpharmaka zur Therapie der Hepatitis C
US6652836B2 (en)	1998-10-15	2003-11-25	Fluoroprobe, Inc.	Method for viewing tumor tissue located within a body cavity
US6870914B1 (en) *	1999-01-29	2005-03-22	Sbc Properties, L.P.	Distributed text-to-speech synthesis between a telephone network and a telephone subscriber unit
MY133346A (en)	1999-03-01	2007-11-30	Biogen Inc	Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en)	1999-03-01	2002-08-01	Paul Chinn	Radiolabeling kit and binding assay
US6254852B1 (en)	1999-07-16	2001-07-03	Dupont Pharmaceuticals Company	Porous inorganic targeted ultrasound contrast agents
US6358491B1 (en) *	1999-08-27	2002-03-19	Berlex Laboratories, Inc.	Somatostatin analogs
US6685914B1 (en)	1999-09-13	2004-02-03	Bristol-Myers Squibb Pharma Company	Macrocyclic chelants for metallopharmaceuticals
US7067111B1 (en) *	1999-10-25	2006-06-27	Board Of Regents, University Of Texas System	Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
GB0018891D0 (en)	2000-08-01	2000-09-20	Novartis Ag	Organic compounds
DK1286704T3 (da)	2000-06-02	2014-09-22	Univ Texas	Ethylendicystein (EC)-glucose analoge konjugater
US7385025B2 (en)	2000-12-19	2008-06-10	Palatin Technologies, Inc.	Metallopeptide compounds
FR2845389B1 (fr) *	2002-10-04	2007-01-12	Solvay	Procede pour la synthese de peptides comprenant au moins une molecule de glycine
JP2006522100A (ja) *	2003-03-10	2006-09-28	バイオジェンアイデックインク	標的化ペプチドに対するチオール媒介性薬物結合
PE20050285A1 (es)	2003-06-24	2005-06-09	Novartis Ag	Composicion farmaceutica que comprende analogos ciclicos de somatostatina
CN100475271C (zh)	2003-08-20	2009-04-08	加利福尼亚大学董事会	具有抑制生长激素释放活性的促生长素抑制素类似物
US9050378B2 (en) *	2003-12-10	2015-06-09	Board Of Regents, The University Of Texas System	N2S2 chelate-targeting ligand conjugates
US8986650B2 (en)	2005-10-07	2015-03-24	Guerbet	Complex folate-NOTA-Ga68
CA2625196C (fr)	2005-10-07	2016-04-05	Guerbet	Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
US8758723B2 (en)	2006-04-19	2014-06-24	The Board Of Regents Of The University Of Texas System	Compositions and methods for cellular imaging and therapy
US10925977B2 (en) *	2006-10-05	2021-02-23	Ceil>Point, LLC	Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2450832C2 (ru) *	2006-10-25	2012-05-20	Конинклейке Филипс Электроникс Н.В.	Контрастные вещества для детекции рака предстательной железы
WO2009039207A1 (en) *	2007-09-19	2009-03-26	Oncofluor, Inc.	Method for imaging and treating organs and tissues
FR2942227B1 (fr)	2009-02-13	2011-04-15	Guerbet Sa	Utilisation de tampons pour la complexation de radionucleides
FR2968999B1 (fr)	2010-12-20	2013-01-04	Guerbet Sa	Nanoemulsion de chelate pour irm
FR2980364B1 (fr)	2011-09-26	2018-08-31	Guerbet	Nanoemulsions et leur utilisation comme agents de contraste
US20140147381A1 (en) *	2012-11-29	2014-05-29	Gregory David Espenan	89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
FR3001154B1 (fr)	2013-01-23	2015-06-26	Guerbet Sa	Magneto-emulsion vectorisee
AU2013383382B2 (en)	2013-03-15	2017-02-23	Purdue Research Foundation	Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
AU2016287304A1 (en) *	2015-06-30	2018-01-04	Tarveda Therapeutics, Inc.	Targeted conjugates and particles and formulations thereof
WO2020007822A1 (en)	2018-07-02	2020-01-09	Conservatoire National Des Arts Et Metiers (Cnam)	Bismuth metallic (0) nanoparticles, process of manufacturing and uses thereof
WO2022115778A1 (en) *	2020-11-30	2022-06-02	Rayzebio, Inc.	Radiopharmaceutical conjugate compositions and uses thereof

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH379524A (de)	1959-05-05	1964-07-15	Inventa Ag	Verfahren zur Herstellung von Methionin
NL7607987A (nl) *	1975-08-08	1977-02-10	Merck & Co Inc	Werkwijze voor het bereiden van peptiden.
CA1083143A (en) *	1976-01-02	1980-08-05	Nedumparambil A. Abraham	Carba derivatives of somatostatin and process therefor
US4244947A (en) *	1979-08-13	1981-01-13	Ayerst Mckenna And Harrison Inc.	Carba decapeptide derivatives of [TYR6 ]-somatostatin
US4235886A (en) *	1979-10-31	1980-11-25	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4444690A (en) *	1982-02-25	1984-04-24	University Patents, Inc.	Technetium chelates
US4472509A (en) *	1982-06-07	1984-09-18	Gansow Otto A	Metal chelate conjugated monoclonal antibodies
DE3379657D1 (en) *	1982-12-06	1989-05-24	Merck & Co Inc	Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
US4485101A (en) *	1983-10-11	1984-11-27	Administrators Of The Tulane Educational Fund	Peptides
US4684620A (en) *	1984-09-04	1987-08-04	Gibson-Stephens Neuropharmaceuticals, Inc.	Cyclic polypeptides having mu-receptor specificity
HUT42101A (en) *	1985-01-07	1987-06-29	Sandoz Ag	Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) *	1985-04-25	1987-03-17	Schally Andrew Victor	Biologically active octapeptides
US4611054A (en) *	1985-04-29	1986-09-09	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4612366A (en) *	1985-06-17	1986-09-16	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
US4904642A (en) *	1985-09-12	1990-02-27	The Administrators Of The Tulane Educational Fund	Therapeutic somatostatin analogs
US4877868A (en) *	1986-03-12	1989-10-31	Neorx Corporation	Radionuclide antibody coupling
US4853371A (en) *	1986-06-17	1989-08-01	The Administrators Of The Tulane Educational Fund	Therapeutic somatostatin analogs
US4871717A (en) *	1987-01-07	1989-10-03	Administrators Of The Tulane Educational Fund	Peptides
WO1988007382A2 (en) *	1987-04-02	1988-10-06	Centocor Cardiovascular Imaging Partners, L.P.	Method for labelling antibodies with a metal ion
US5073541A (en) *	1987-11-18	1991-12-17	Administrators Of The Tulane Educational Fund	Treatment of small cell lung cancer with somatostatin analogs
US5395946A (en) *	1988-02-09	1995-03-07	Goedemans; Wilhelmus T.	Bifunctional chelating agents
WO1989010759A1 (en) *	1988-04-29	1989-11-16	Mallinckrodt, Inc.	Diaminedithiol chelating agents for radiopharmaceuticals
US4988496A (en) *	1988-05-31	1991-01-29	Neorx Corporation	Metal radionuclide chelating compounds for improved chelation kinetics
GB9111199D0 (en) *	1991-05-23	1991-07-17	Sandoz Ltd	Improvements in or relating to organic compounds
MY106120A (en) *	1988-12-05	1995-03-31	Novartis Ag	Peptide derivatives.
US5066716A (en) *	1988-12-13	1991-11-19	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US5196510A (en) *	1988-12-29	1993-03-23	Cytogen Corporation	Molecular recognition units
CA2012115C (en) *	1989-03-15	2001-07-03	Biomeasure, Inc.	Iodinated somatostatins
US5095111A (en) *	1989-03-17	1992-03-10	The John Hopkins University	Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
JP2882679B2 (ja) *	1989-04-26	1999-04-12	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	線状ソマトスタチン類似体
DE69018226T2 (de) *	1989-07-20	1995-09-21	Sandoz-Patent-Gmbh, 79539 Loerrach	Markierte polypeptidderivate.
US5443816A (en) *	1990-08-08	1995-08-22	Rhomed Incorporated	Peptide-metal ion pharmaceutical preparation and method
US5460785A (en) *	1989-08-09	1995-10-24	Rhomed Incorporated	Direct labeling of antibodies and other protein with metal ions
ES2091907T3 (es) *	1989-12-08	1996-11-16	Univ Tulane	Analogos octapeptidos de somatostina con una threonina en la sexta posicion.
IL97459A0 (en) *	1990-03-09	1992-06-21	Hybritech Inc	Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
ATE124054T1 (de) *	1990-04-06	1995-07-15	Univ Tulane	Somatostatinanaloge.
US5382654A (en) *	1992-02-05	1995-01-17	Mallinckrodt Medical, Inc.	Radiolabelled peptide compounds
ATE181240T1 (de) *	1991-02-08	1999-07-15	Biomeasure Inc	Verwendung von somatostatinanalogen zur behandlung von melanomen
US5443815A (en) *	1991-11-27	1995-08-22	Diatech, Inc.	Technetium-99m labeled peptides for imaging
US5409894A (en) *	1991-03-14	1995-04-25	Sandoz Ltd.	Method of preventing balloon catheterization blood vessel damage
AU657770B2 (en) *	1991-06-03	1995-03-23	Mallinckrodt Medical, Inc.	Radiolabelled somatostatin derivatives, their preparation and use
AU664855B2 (en) *	1991-08-09	1995-12-07	Winfried Kolbeck	Lanthionine bridged peptides
US5225180A (en) *	1991-09-10	1993-07-06	Diatech, Inc.	Technetium-99m labeled somatostatin-derived peptides for imaging
WO1995000553A1 (en) *	1993-06-23	1995-01-05	Diatech, Inc.	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5508020A (en) *	1992-06-05	1996-04-16	Diatech, Inc.	Technetium-99M labeled peptides for imaging
US5620675A (en) *	1992-06-23	1997-04-15	Diatech, Inc.	Radioactive peptides
US5443806A (en) *	1994-03-22	1995-08-22	A. Ahlstrom Corporation	Treating exhaust gas from a pressurized fluidized bed reaction system

1992
- 1992-06-23 US US07/902,935 patent/US5716596A/en not_active Expired - Fee Related
1993
- 1993-06-23 AT AT93918129T patent/ATE203754T1/de not_active IP Right Cessation
- 1993-06-23 DE DE69330521T patent/DE69330521T2/de not_active Expired - Fee Related
- 1993-06-23 ES ES93918129T patent/ES2164667T3/es not_active Expired - Lifetime
- 1993-06-23 EP EP00122243A patent/EP1094074A3/de not_active Withdrawn
- 1993-06-23 CA CA002138647A patent/CA2138647C/en not_active Expired - Fee Related
- 1993-06-23 DK DK93918129T patent/DK0649434T3/da active
- 1993-06-23 AU AU47688/93A patent/AU690071B2/en not_active Ceased
- 1993-06-23 JP JP6502568A patent/JPH08503924A/ja not_active Expired - Lifetime
- 1993-06-23 EP EP93918129A patent/EP0649434B1/de not_active Expired - Lifetime
- 1993-06-23 WO PCT/US1993/006029 patent/WO1994000489A2/en not_active Ceased
1995
- 1995-06-06 US US08/466,100 patent/US5820845A/en not_active Expired - Fee Related
- 1995-06-06 US US08/470,932 patent/US5833942A/en not_active Expired - Fee Related
- 1995-06-06 US US08/467,025 patent/US5843401A/en not_active Expired - Fee Related
- 1995-06-06 US US08/465,764 patent/US5814298A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US5716596A (en)	1998-02-10
EP1094074A2 (de)	2001-04-25
US5833942A (en)	1998-11-10
US5843401A (en)	1998-12-01
US5814298A (en)	1998-09-29
WO1994000489A2 (en)	1994-01-06
EP0649434B1 (de)	2001-08-01
ES2164667T3 (es)	2002-03-01
EP0649434A1 (de)	1995-04-26
US5820845A (en)	1998-10-13
AU690071B2 (en)	1998-04-23
CA2138647A1 (en)	1994-01-06
CA2138647C (en)	2002-11-12
EP1094074A3 (de)	2002-01-09
JPH08503924A (ja)	1996-04-30
DE69330521T2 (de)	2002-05-16
DK0649434T3 (da)	2001-11-12
WO1994000489A3 (en)	1994-03-31
AU4768893A (en)	1994-01-24
DE69330521D1 (de)	2001-09-06

Legal Events

Date	Code	Title	Description
2002-01-15	UEP	Publication of translation of european patent specification
2008-03-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69330521D1 (de)	2001-09-06	Radioaktiv-markierte peptidderivate des somatostatin zur bildformenden und therapeutischen verwendung
ATE337338T1 (de)	2006-09-15	Radioaktiv-markierte peptidderivate des somatostatins zur bildformenden und therapeutischen verwendung
DE69232418D1 (de)	2002-03-21	Technetium - 99M markierte Peptide zur Bildformung
CA2167678A1 (en)	1995-02-02	Radioactive peptides
MX9707426A (es)	1998-07-31	Peptidos marcados radioactivamente para diagnostico y terapia.
ATE184203T1 (de)	1999-09-15	Technetium-99m-markierte peptide zur bilderzeugung
ATE237365T1 (de)	2003-05-15	Technetium-99-markierte peptide zur visualisierung vom entzuendungen
DE69329382D1 (de)	2000-10-12	Technetium-99m markierte peptide zur bilderzeugung von thrombus
CA2195395A1 (en)	1996-02-15	Cyclic hexapeptide somatostatin analogues
DK0762901T3 (da)	2006-08-21	Technetium-99m-mærkede peptider til imagografi
BR9810907A (pt)	2000-08-01	Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
AU4611589A (en)	1990-06-28	Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof.
CA2347670A1 (en)	1995-01-05	Radiolabeled somatostatin-derived peptides for imaging